How Roche drives AI outcomes in a changing world

Roche is integrating AI across its healthcare and pharmaceutical value chain—from predictive chronic kidney disease algorithms and digital pathology to clinical trial simulations and manufacturing digital twins—supported by dedicated Chief AI and Chief Data Officer roles. This initiative demonstrates how healthcare and pharmaceutical organizations can approach AI adoption as an end-to-end business process and change management challenge requiring robust data foundations. It provides a real-world model for balancing strict patient safety and ethical governance with the operational speed needed to scale digital innovation.

Summary written by AI Business Lens with an AI model from the article at cio.com. It is not the article, and the publisher has not reviewed it. For publishers.

Read the original at cio.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, class prep, and an exercise. All built from the full article. Three are free with an account. Stories stay on the brief for 14 days; after that this page keeps the link to the original.

More in Health Administration

• Is Overreliance on AI Causing Agency Decay?Knowledge at Wharton · September 16, 2026
• ‘I’ve just done about 2 weeks' work in an hour. Do I tell my boss or keep it secret?’ — Nearly a third of AI users are hiding it from their employersTechRadar · September 16, 2026
• New portable blood testing device could allow patient health to be monitored at home through an appMedical Xpress · September 16, 2026
• From 7,000 drugs to one active against resistant strains: AI advances pneumonia drug repurposingMedical Xpress · September 16, 2026
• AI Isn’t a Therapist, but Many Teens Are Treating It Like OneMedCity News · September 16, 2026